Lv3
366 积分 2025-05-06 加入
Drugging p53 in cancer: one protein, many targets
1个月前
已完结
Reactivating p53 mutants selectively in patients
1个月前
已完结
Revisiting p53 as a therapeutic target: emerging clinical evidence in gynecologic oncology
1个月前
已关闭
Revisiting p53 as a therapeutic target: emerging clinical evidence in gynecologic oncology
1个月前
已关闭
Ovarian Cancer Therapy
2个月前
已完结
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
3个月前
已完结
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
3个月前
已完结
Clinical characteristics and management of headache in patients with myeloproliferative neoplasms
3个月前
已完结
Unique features of primary myelofibrosis in Chinese
3个月前
已完结
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems
3个月前
已完结
皖公网安备34019202002308
